Federal rescheduling fuels cannabis M&A, but integration—not deal size—decides who thrives. What this shift means for Virginia, DC, and Maryland weed delivery laws.

Curaleaf launched a hostile takeover offer for Aurora, moving the proposal directly to investors. Here’s what that could mean for product supply, delivery compliance, and DMV consumers.

Aurora told investors to reject Curaleaf’s unsolicited $272M hostile bid and formed a special committee. Here’s what it could mean for delivery models, investors, and the DMV market.

The Minnesota-based operator purchased the Hawthorne, Nevada dispensary in a cash-and-stock deal with a performance earnout through 2029. Here’s why DMV readers should care.

TerrAscend expands its New Jersey footprint with a $9 million cash-and-debt purchase, bringing the MSO to five Garden State stores and signaling more consolidation ahead.

Curaleaf urges Aurora investors to accept a $4-per-share hostile offer it says carries a 45% VWAP premium; Aurora calls the bid inadequate and risky. Here’s the business impact and DMV angle.

Christina Lake Cannabis is reviewing dueling offers—one to buy the company, one to buy its assets. Here’s what the $15M vs $18M spread could signal for delivery models and investors.

Congress’s hemp pause, closing arguments in the rescheduling case, a major M&A rebuff, and compliance warnings headline the week’s cannabis policy and business shifts.

Aurora says it is debt‑free with CA$149M cash and urges shareholders to reject Curaleaf’s hostile $4‑per‑share offer, warning the deal discounts assets and shifts risk.